CSR & 3D Printing: driving sustainable innovation in medtech
Discover how MB Therapeutics integrates CSR and innovation into its practices through 3D printing and the circular economy for a more sustainable future.
Discover how MB Therapeutics integrates CSR and innovation into its practices through 3D printing and the circular economy for a more sustainable future.
As part of its expansion and commitment to ensuring the highest standards of pharmaceutical quality, MB Therapeutics is pleased to announce the integration of Manon Perez as responsible pharmacist and Chief Quality Officer (CQO).
MB Therapeutics has settled into its new premises. New address, same tight-knit team, and even more energy!
From Rotterdam to Lyon… The MB Therapeutics team took part in key events where pharmaceutical innovation was at the heart of the discussions.
MB Therapeutics raises €2 million to industrialize and launch a solution for the manufacturing of personalized medicines in pharmacies.
A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!
Discover the essentials of Good Manufacturing Practices (GMP) for the pharmaceutical industry. Ensure compliance with regulatory quality and safety standards.
What if you had the choice of your medication?
Discover the benefits of pharmaceutical 3D printing of medications for patients.